Investor Presentaiton

Blazing a trail to the first FDA approved and reimbursed CRC screening test INVESTOR 20 DAY 23 Launched Shield LDT ECLIPSE Readout Filed PMA with FDA Published staging data at DDW Launch Shield IVD-CRC TM shield May 2022 4Q' 22 1Q' 23 2Q' 23 2024 GUARDANT™ CRC Drives Medicare reimbursement with $0 co-pay Medicare & ADLT Status ACS Guidelines USPSTF Guidelines ADLT Pricing 2026 State-level payer reimbursement opportunity Drives private payer reimbursement with $0 co-pay 112

View entire presentation